Veterinary Medicines

PA-OLVAC +I+E Vaccino inattivato in emulsione iniettabile per tacchini

Authorised
  • Turkey haemorrhagic enteritis virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
Download as PDF

Product identification

Medicine name:
PA-OLVAC +I+E Vaccino inattivato in emulsione iniettabile per tacchini
Active substance:
  • Turkey haemorrhagic enteritis virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
Target species:
  • Turkey
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey haemorrhagic enteritis virus, Inactivated
    1733.00
    enzyme-linked immunosorbent assay unit
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Riemerella anatipestifer, serotype 1, Inactivated
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Riemerella anatipestifer, serotype 3, Inactivated
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Influenza A virus, subtype H9N2 (avian), Inactivated
  • Influenza A virus, subtype H6N2 (avian), Inactivated
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download